preclinics logotype
News item

Platform for single-domain camelid antibody generation

We join forces with InSCREENeX GmbH to develop a new platform for single-domain camelid antibody generation.
The platform is based on an expandable llama immunization cell line. The collaboration combines InSCREENeX’ unique know-how in generation of expandable cell lines from any species with preclinics’ leading expertise in camelid immunization. The novel platform will greatly enhance the generation of camelid antibodies against difficult drug targets for example low immunogenic membrane-spanning proteins.